Empowered Funds’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.9M | Buy |
36,800
+16,016
| +77% | +$9.02M | 0.11% | 196 |
|
|
2026
Q1 | $12.3M | Sell |
20,784
-23,607
| -53% | -$11.8M | 0.08% | 294 |
|
|
2025
Q4 | $21.6M | Buy |
44,391
+18,849
| +74% | +$8.78M | 0.37% | 53 |
|
|
2025
Q3 | $10.7M | Sell |
25,542
-37,988
| -60% | -$12.8M | 0.11% | 201 |
|
|
2025
Q2 | $18.3M | Buy |
63,530
+5,555
| +10% | +$1.66M | 0.21% | 95 |
|
|
2025
Q1 | $17.9M | Buy |
57,975
+36,443
| +169% | +$12.5M | 0.25% | 68 |
|
|
2024
Q4 | $7.6M | Sell |
21,532
-2,697
| -11% | -$991K | 0.11% | 246 |
|
|
2024
Q3 | $8.68M | Sell |
24,229
-25,412
| -51% | -$8.58M | 0.14% | 180 |
|
|
2024
Q2 | $15.8M | Buy |
49,641
+7,884
| +19% | +$2.09M | 0.27% | 53 |
|
|
2024
Q1 | $9.59M | Buy |
41,757
+19,073
| +84% | +$4.3M | 0.17% | 131 |
|
|
2023
Q4 | $4.99M | Sell |
22,684
-2,799
| -11% | -$645K | 0.13% | 233 |
|
|
2023
Q3 | $5.76M | Buy |
+25,483
| New | +$5.87M | 0.17% | 137 |
|
|
2023
Q2 | – | Sell |
-10,917
| Closed | -$2.44M | – | 1180 |
|
|
2023
Q1 | $2.44M | Buy |
+10,917
| New | +$2.69M | 0.14% | 191 |
|
|
2022
Q3 | – | Sell |
-18,439
| Closed | -$4.34M | – | 381 |
|
|
2022
Q2 | $4.34M | Buy |
+18,439
| New | +$3.75M | 0.56% | 43 |
|
|
2021
Q2 | – | Sell |
-18,781
| Closed | -$2.85M | – | 306 |
|
|
2021
Q1 | $2.85M | Hold |
18,781
| – | – | 0.55% | 38 |
|
|
2020
Q4 | $2.85M | Sell |
18,781
-8,670
| -32% | -$1.14M | 0.55% | 38 |
|
|
2020
Q3 | $2.77M | Buy |
27,451
+5,668
| +26% | +$622K | 0.87% | 41 |
|
|
2020
Q2 | $2.64M | Buy |
+21,783
| New | +$2.45M | 1.02% | 25 |
|
|
2019
Q4 | – | Sell |
-26,196
| Closed | -$2.09M | – | 141 |
|
|
2019
Q3 | $2.09M | Buy |
26,196
+1,236
| +5% | +$99.5K | 0.91% | 40 |
|
|
2019
Q2 | $1.95M | Buy |
24,960
+3,023
| +14% | +$283K | 0.81% | 44 |
|
|
2019
Q1 | $2.58M | Buy |
+21,937
| New | +$2.56M | 0.92% | 18 |
|
|
2018
Q1 | – | Sell |
-16,924
| Closed | -$2.5M | – | 121 |
|
|
2017
Q4 | $2.5M | Buy |
16,924
+3,703
| +28% | +$471K | 1.26% | 10 |
|
|
2017
Q3 | $1.55M | Buy |
13,221
+534
| +4% | +$68.2K | 1.01% | 44 |
|
|
2017
Q2 | $1.65M | Buy |
12,687
+2,018
| +19% | +$252K | 1.33% | 29 |
|
|
2017
Q1 | $1.44M | Buy |
+10,669
| New | +$1.62M | 1.48% | 39 |
|
Other funds holding UTHR
ACA
JT
Empowered Funds's UTHR Position: Q2 2026 in Review
Empowered Funds increased its United Therapeutics (UTHR) stake by 77% in Q2 2026, buying an estimated $9.02M and bringing the position to 36,800 shares worth $19.9M. The position accounts for 0.11% of the portfolio, ranked #196.
Empowered Funds first reported a position in UTHR in Q1 2017 and has held it in 25 quarters since. The position peaked at $21.6M in Q4 2025. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Empowered Funds held 36,800 shares of United Therapeutics worth $19.9M as of Q2 2026.
- Empowered Funds bought 16,016 United Therapeutics shares in Q2 2026, an estimated $9.02M.
- United Therapeutics made up 0.11% of Empowered Funds's portfolio in Q2 2026, its #196 holding.
- Empowered Funds first reported a position in United Therapeutics in Q1 2017 and has held it in 25 quarters since.
- Empowered Funds's United Therapeutics position peaked at $21.6M in Q4 2025.
- 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.